Fortrea Holdings (FTRE) Cost of Revenue (2022 - 2026)

Fortrea Holdings (FTRE) reported Cost of Revenue of $512.9 million for Q1 2026, down 4.09% on a YoY basis from $534.8 million in Q1 2025, and down 3.12% quarter-over-quarter from $529.4 million in Q4 2025.

Fortrea Holdings (FTRE) Cost of Revenue (2022 - 2026) Analysis & Trends

Fortrea Holdings has reported Cost of Revenue for 5 years, with the latest figure at $512.9 million in Q1 2026.

  • For the quarter ending Q1 2026, Cost of Revenue fell 4.09% year-over-year to $512.9 million; the trailing twelve-month figure through Mar 2026 stood at $2.2 billion (up 2.56% YoY), and the FY2025 full-year result was $2.2 billion, up 2.65% from the prior year.
  • Cost of Revenue for Q1 2026 stood at $512.9 million, down from $529.4 million in the prior quarter.
  • The five-year high for Cost of Revenue was $614.3 million in Q2 2022, with the low at $265.0 million in Q4 2022.
  • Historically, Cost of Revenue has averaged $538.8 million across 5 years, with a median of $555.2 million in 2024.
  • Annual changes were most pronounced in 2023 — Cost of Revenue jumped 118.08% — and 2024, when it decreased 7.63%.
  • Fortrea Holdings' Cost of Revenue stood at $265.0 million in 2022, then jumped by 118.08% to $577.9 million in 2023, then declined by 3.77% to $556.1 million in 2024, then fell by 4.8% to $529.4 million in 2025, then declined by 3.12% to $512.9 million in 2026.
  • The last three Cost of Revenue figures came in at $512.9 million (Q1 2026), $529.4 million (Q4 2025), and $578.6 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cost of Rev (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 64.20 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 48,670.00
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 392.80 Mn
9 Abivax 91.96 Bn 91.96 Bn - 2.05 Mn
10 Fortrea Holdings 1.43 Bn 1.28 Bn 123.60 Mn 512.90 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 512.90 Mn
Mar 31, 2026 512.90 Mn
Dec 31, 2025 529.40 Mn
Dec 31, 2025 529.40 Mn
Sep 30, 2025 578.60 Mn
Sep 30, 2025 578.60 Mn
Jun 30, 2025 576.80 Mn
Jun 30, 2025 576.80 Mn
Mar 31, 2025 534.80 Mn
Mar 31, 2025 534.80 Mn
Dec 31, 2024 556.10 Mn
Dec 31, 2024 556.10 Mn
Sep 30, 2024 526.60 Mn
Sep 30, 2024 526.60 Mn
Jun 30, 2024 525.30 Mn
Jun 30, 2024 525.30 Mn
Mar 31, 2024 554.20 Mn
Mar 31, 2024 554.20 Mn
Dec 31, 2023 577.90 Mn
Dec 31, 2023 577.90 Mn